journal article·2026-04-19Open access

ATP-Responsive Bimetallic Metal–Organic Frameworks Amplify Oxidative Stress in the Tumor Microenvironment for Synergistic Chemo-Immunotherapy

You Li, Wenxin Zhang, Zitao Xu, Shixin Ma, Yufei Xiong, Li Yu, Huiling Gao, Yang Shu, Teng Fei

Abstract

Metal ion-based chemo-immunotherapy is often limited by rigid intracellular metal homeostasis, insufficient reactive oxygen species (ROS) accumulation, and an immunosuppressive tumor microenvironment (TME). To overcome these limitations, we engineered an ATP-responsive, core–shell bimetallic nanoreactor (Cu/ZIF@PDA, termed CZP) featuring a precisely controlled ~25 nm biomimetic polydopamine (PDA) coating. Triggered by elevated tumoral ATP levels, CZP undergoes coordination-induced disassembly and promotes oxidative stress amplification. Specifically, the PDA shell acts as a superoxide dismutase (SOD) mimetic to continuously supply H2O2, fueling Cu2+-mediated Fenton-like reactions to unleash highly toxic hydroxyl radicals (•OH) while aggressively depleting the intracellular glutathione (GSH) pool. This irreversible oxidative damage, coupled with Zn2+-induced mitochondrial dysfunction, triggers profound mitochondrial DNA (mtDNA) leakage. Crucially, this cytosolic DNA robustly activates the cGAS-STING signaling axis, driving a massive surge in immunogenic cell death (ICD) and significantly promoting dendritic cell (DC) maturation. Furthermore, CZP markedly inhibited primary tumor growth in vivo and showed protection in a tumor re-challenge model, accompanied by enhanced dendritic cell maturation. These findings support the potential of this ATP-responsive bimetallic nanoplatform to promote antitumor immune activation.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · interferon and immune responses · Cancer, Hypoxia, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Bioresource Research and Development of Liaoning Province, College of Life and Health Sciences, Northeastern University, Shenyang 110819, China

National Frontiers Science Center for Industrial Intelligence and Systems Optimization, Northeastern University, Shenyang 110819, China

Key Laboratory of Data Analytics and Optimization for Smart Industry (Northeastern University), Ministry of Education, Shenyang 110819, China

Department of Chemistry, College of Sciences, Northeastern University, Shenyang 110819, China

Funding

National Key Research and Development Program of China · 111 Project · Construction Project of Liaoning Provincial Key Laboratory, China

References (36)

Show source-provided references
1. Cancer statistics, 2025
2. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
3. Molecular mechanisms of tumor resistance to radiotherapy10.1186/s12943-023-01801-2 ↗
4. Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions10.1016/j.jtho.2020.11.002 ↗
5. Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors10.1016/j.ccell.2024.05.025 ↗
6. ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity10.1016/j.cell.2024.04.025 ↗
7. Turning cold tumors hot: From molecular mechanisms to clinical applications10.1016/j.it.2022.04.010 ↗
8. Turning cold tumors into hot tumors to ignite immunotherapy10.1186/s12943-025-02477-6 ↗
9. NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistance10.1016/j.cmet.2023.07.009 ↗
10. Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity10.1038/s41590-022-01379-9 ↗
11. IL-36gamma armored CAR T cells reprogram neutrophils to induce endogenous antitumor immunity10.1016/j.ccell.2025.11.007 ↗
12. NF-kappaB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment10.1126/sciadv.adq5226 ↗
13. Immunologic tumor microenvironment modulators for turning cold tumors hot10.1002/cac2.12539 ↗
14. 25-Hydroxycholesterol regulates lysosome AMP kinase activation and metabolic reprogramming to educate immunosuppressive macrophages10.1016/j.immuni.2024.03.021 ↗
15. Thermosensitive Resiquimod-Loaded Lipid Nanoparticles Promote the Polarization of Tumor-Associated Macrophages to Enhance Bladder Cancer Immunotherapy10.1021/acsnano.4c17444 ↗
16. Self-Assembled STING-Activating Coordination Nanoparticles for Cancer Immunotherapy and Vaccine Applications10.1021/acsnano.3c11374 ↗
17. Metallodrugs in cancer nanomedicine10.1039/D1CS00468A ↗
18. Synthesis of Iron Nanometallic Glasses and Their Application in Cancer Therapy by a Localized Fenton Reaction10.1002/anie.201510031 ↗
19. Bidirectionally H2O2-suppliable and antioxidant-consumable copper peroxide nanoparticles for photochemodynamic immunotherapy10.1016/j.biomaterials.2026.123988 ↗
20. Coordination Self-Assembly of a Carrier-Free Hyaluronic Acid-Modified Nanoplatform for Augmented Photothermal/Chemodynamic Therapy and Robust Antimetastatic Immunity10.1021/acsami.5c24185 ↗
21. Mitigating Doxorubicin-Induced Cardiotoxicity and Enhancing Anti-Tumor Efficacy with a Metformin-Integrated Self-Assembled Nanomedicine10.1002/advs.202415227 ↗
22. The progression of inorganic nanoparticles and natural products for inflammatory bowel disease10.1186/s12951-023-02246-x ↗
23. Concurrent Amplification of Ferroptosis and Immune System Activation Via Nanomedicine-Mediated Radiosensitization for Triple-Negative Breast Cancer Therapy10.1002/advs.202407833 ↗
24. Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy10.1016/j.biomaterials.2021.121110 ↗
25. NIR-Actuated Ferroptosis Nanomotor for Enhanced Tumor Penetration and Therapy10.1002/adma.202412227 ↗
26. Tumor acidification and GSH depletion by bimetallic composite nanoparticles for enhanced chemodynamic therapy of TNBC10.1186/s12951-024-02308-8 ↗
27. The cGAS–STING pathway in cancer immunity: Mechanisms, challenges, and therapeutic implications10.1186/s13045-025-01691-5 ↗
28. cGAS-STING, an important signaling pathway in diseases and their therapy10.1002/mco2.511 ↗
29. Demystifying the cGAS-STING pathway: Precision regulation in the tumor immune microenvironment10.1186/s12943-025-02380-0 ↗
30. Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity10.1038/s41467-023-39607-x ↗
31. Nrf2 silencing amplifies DNA photooxidative damage to activate the STING pathway for synergistic tumor immunotherapy10.1016/j.biomaterials.2023.122068 ↗
32. Stimuli-responsive cancer nanomedicines inhibit glycolysis and impair redox homeostasis10.1016/j.actbio.2023.06.016 ↗
33. Multimodal smart systems reprogramme macrophages and remove urate to treat gouty arthritis10.1038/s41565-024-01715-0 ↗
34. Fusiform-Like Copper(II)-Based Metal-Organic Framework through Relief Hypoxia and GSH-Depletion Co-Enhanced Starvation and Chemodynamic Synergetic Cancer Therapy10.1021/acsami.0c01539 ↗
35. H2O2 and Phosphorylated Peptide Dual-Responsive Nanochannel Device10.1021/acs.analchem.3c01458 ↗
36. Metal-organic framework-based hydrogel with structurally dynamic properties as a stimuli-responsive localized drug delivery system for cancer therapy10.1016/j.actbio.2022.04.003 ↗